Patents by Inventor Mark Lowdell

Mark Lowdell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for activating natural killer cells by tumor cell preparation in vitro
    Patent number: 9655925
    Abstract: The present invention provides a method for activating a Natural Killer (NK) cell by contacting the NK cell in vitro with an activating tumor cell preparation (ATCP). The invention also provides an activated NK cell produced by such a method and its use in the treatment of cancer.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: May 23, 2017
    Assignee: UCL BIOMEDICA PLC
    Inventor: Mark Lowdell
  • Preserved compositions of activated NK cells and methods of using the same
    Patent number: 8735148
    Abstract: Disclosed herein are activated NK cells that exhibit durable and prolonged activity in the absence of the activating agent and retain their activated state after preservation. Methods of administrating the NK cells to a patient do not require co-administration of the activating agent, and thus, pharmaceutical compositions comprising the NK cells may remain substantially free of the activating agent.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: May 27, 2014
    Assignee: UCL Business PLC
    Inventor: Mark Lowdell
  • Method for Activating Natural Killer Cells by Tumor Cell Preparation In Vitro
    Publication number: 20140079678
    Abstract: The present invention provides a method for activating a Natural Killer (NK) cell by contacting the NK cell in vitro with an activating tumour cell preparation (ATCP). The invention also provides an activated NK cell produced by such a method and its use in the treatment of cancer.
    Type: Application
    Filed: November 21, 2013
    Publication date: March 20, 2014
    Applicant: UCL Biomedica PLC
    Inventor: Mark LOWDELL
  • Method for activating natural killer cells by tumor cell preparation in vitro
    Patent number: 8637308
    Abstract: The present invention provides a method for activating a Natural Killer (NK) cell by contacting the NK cell in vitro with an activating tumor cell preparation (ATCP). The invention also provides an activated NK cell produced by such a method and its use in the treatment of cancer.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: January 28, 2014
    Assignee: UCL Biomedica PLC
    Inventor: Mark Lowdell
  • Method for Activating Natural Killer Cells by Tumor Cell Preparation In Vitro
    Publication number: 20120328587
    Abstract: The present invention provides a method for activating a Natural Killer (NK) cell by contacting the NK cell in vitro with an activating tumour cell preparation (ATCP). The invention also provides an activated NK cell produced by such a method and its use in the treatment of cancer.
    Type: Application
    Filed: August 31, 2012
    Publication date: December 27, 2012
    Applicant: UCL Biomedica PLC
    Inventor: Mark LOWDELL
  • Method for activating natural killer cells by tumor cell preparation in vitro
    Patent number: 8257970
    Abstract: The present invention provides a method for activating a Natural Killer (NK) cell by contacting the NK cell in vitro with an activating tumor cell preparation (ATCP). The invention also provides an activated NK cell produced by such a method and its use in the treatment of cancer.
    Type: Grant
    Filed: September 17, 2007
    Date of Patent: September 4, 2012
    Assignee: UCL Biomodica PLC
    Inventor: Mark Lowdell
  • Preserved Compositions of Activated NK Cells and Methods of Using the Same
    Publication number: 20110014162
    Abstract: Disclosed herein are activated NK cells that exhibit durable and prolonged activity in the absence of the activating agent and retain their activated state after preservation. Methods of administrating the NK cells to a patient do not require co-administration of the activating agent, and thus, pharmaceutical compositions comprising the NK cells may remain substantially free of the activating agent.
    Type: Application
    Filed: July 9, 2010
    Publication date: January 20, 2011
    Inventor: Mark LOWDELL
  • Method for activating natural killer cells by tumor cell preparation in vitro
    Publication number: 20080166326
    Abstract: The present invention provides a method for activating a Natural Killer (NK) cell by contacting the NK cell in vitro with an activating tumour cell preparation (ATCP). The invention also provides an activated NK cell produced by such a method and its use in the treatment of cancer.
    Type: Application
    Filed: September 17, 2007
    Publication date: July 10, 2008
    Inventor: Mark Lowdell